Request edit access
JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
台灣病理學會主辦分子能力測試 2016 ER(IHC) B1
* Indicates required question
請填寫貴單位 ID:
*
請参閱寄給貴單位的填表說明，裡面有附上貴單位之 ID
Your answer
Institute:
*
Your answer
Testing personnel:
*
Your answer
Lab directors:
*
Your answer
E-mail:
*
請填寫聯絡人的 E-mail 地址
Your answer
1.請問貴單位使用何種固定液?
*
A.10% Neutral buffered formalin
B.Zinc formalin
C.Commercial formalin alternative
D.Alcoholic formalin
Other:
2.貴單位ER IHC的方法為
*
A.Manual staining
B.Autostainer - Dako
C.Autostainer - Leica
D.Autostainer - Thermo
E.Autostainer - Ventana
Other:
3.Antigen retrieval的方法為
*
A.HIER – automated stainer
B.HIER – water bath
C.HIER – steamer
D.HIER – pressure cooker
E.HIER – microwave
F.Protease digestion
G.None
Other:
4.使用 HIER(Heat induced epitope retrieval) 之 buffer為:
*
A.Low pH (<7.0)
B.High pH (>7.0)
C.不使用HIER
5.使用 HIER 之時間為:
*
A.≤15 min
B.16-30 min
C.31-45 min
D.46-60 min
E.>60 min
F.不使用HIER
6.使用的 Primary Ab clone 為
*
A.1D5
B.EP1
C.6F11
D.SP1
Other:
7.使用 Primary Ab 稀釋倍數為:
*
填寫範例:1:50。若貴單位使用 Ready for use antibody，則寫「無」。
Your answer
8.使用的呈色方法為
*
Your answer
9.貴單位是否routine使用image analysis system?
*
A. No
B. Yes (請於底下空格說明貴單位所使用的系統)
使用 image analysis system 的種類 (若有使用請填寫):
Your answer
10.貴單位ER IHC每年檢驗量約為
*
A.<100
B.100-249
C.250-499
D.500-1000
E.>1000
Result
The tissue blocks with inter-observer agreement from 2014-B ER IHC PT are used as positive and negative controls. (positive x 2, negative x 2)
Slide no. you received:
*
Your answer
Percentage:
*
A.No staining
B.<1%
C.1-10%
D.11-50%
E.>50%
F.No invasive tumor cells
G.No tissue
H.Others
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
A.No staining
B.<1%
C.1-10%
D.11-50%
E.>50%
F.No invasive tumor cells
G.No tissue
H.Others
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
若 Percentage 有選「Others」，請於以下空格處說明。若沒有選「Others」，則本項免填。
Your answer
Intensity:
*
1.No staining
2.Weak
3.Intermediate
4.Strong
5.No invasive tumor cells
6.No tissue
7.Others:
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
1.No staining
2.Weak
3.Intermediate
4.Strong
5.No invasive tumor cells
6.No tissue
7.Others:
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
若 Intensity 有選「Others」，請於以下空格處說明。若沒有選「Others」，則本項免填。
Your answer
Interpretation
*
Positive
Negative
Others
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
Positive
Negative
Others
Core2
Core4
Core5
Core6
Core7
Core8
Core9
Core10
Core11
Core12
Core13
Core15
Core17
Core19
Core20
Core21
Core22
Core23
Core24
Core25
Core27
Core28
Core29
Core30
Core31
Core32
Core33
Core35
Core36
Core37
Core38
Core39
Core40
若Interpretation有選「Others」，請於以下空格處說明。若沒有選「Others」，則本項免填。
Your answer
IHC scoring recommended in ASCO/CAP guideline:
Positive for ER or PgR if finding of > 1% of tumor cell nuclei are immunoreactive.
請注意：結果一旦送出即無法修改，請再次檢視您填寫的答案，確認無誤之後再按底下的「提交」按鈕。
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. -
Terms of Service
-
Privacy Policy
Does this form look suspicious?
Report
Forms
Help and feedback
Contact form owner
Help Forms improve
Report
